Laboratory methods in epilepsy and in disorders of cerebral circulation

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 101, Issue 1, 2001, Pages 58-64

  Dambinova, S A ^a   Odinak, M M ^a   Skulyabin, D I ^a   Khunteev, G A ^a   Skvortsova, V I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; BRAIN CIRCULATION; BRAIN ISCHEMIA; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EPILEPSY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; EPILEPSY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 0035219929     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Dingledine R., McBain C.J. Basic neurochemistry: molecular, cellular and medical aspects. Eds. G.J. Siegel et al. 5th ed. New York 1994; 17: 367-387.
2. Farooqui A.A., Haun S.E., Horrocks L.A. Basic neurochemistry: molecular, cellular and medical aspects. Eds. G.J. Siegel et al. 5th ed. New York 1994; 42: 868-882.
3. Fisher R.S., Chan D.W., Bare M., Lesser R.P. Capillary prolactin measurement for diagnosis of siezures. Ann Neurol 1991; 29: 2: 187-190.
4. Giordano M.J., Mahadeo D.K., He Y.Y., Geist R.T., Hsu C., Gutmann D.N. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 1996; 15: 43: 2: 246-253.
5. Granel F., de Maistre E., Challier B., Weber M., Schmutz J.L. Ischemic stroke in young patients and or livedo: is it important to look for anti-beta 2-glycoprotein I antibodies? Rev Med Int 1998; 19: 10: 709-712.
6. Grasia-Naya M., Uson-Martin M., Serrano-Gonzalez C., Sanz-Paris A. Predictive value of serum ferritin in the prognosis of acute cerebrovascular accident. Rev Neurol 1997; 25: 148: 1892-1896.
7. Guerin V., Parrens E., Couchouron A., Freyburger G., Baquey A., Boisseau M. Acute stroke in young female with anti-human beta 2-glycoproteins 1 antibodies. Blood Coagul Fibrinol 1997; 8: 2: 149-151.
8. Lorente de No R. Studies on the structure of the cerebral cortex. Continuation of study of ammonic system. J Psychol Neurol 1943; 46: 113-177.
9. McNamara J.O. Cellular and molecular basis of epilepsy. J Neurosci 1994; 14: 6: 3413-3425.
10. Meldrum B.S. Basic neurochemistry: molecular, cellular and medical aspects. Eds. G.J. Siegel et al. 5th ed. New York 1994; 43: 885-897.
11. Meythaler J.M., Hazlewood J., DeVivo M.J., Rosner M. Elevated liver enzymes after nontraumatic intracranial hemorrhages. Arch Phys Med Rehab 1998; 79: 7: 766-771.
12. Porta Etessam J., Balsalobre Aztar J., Gomez Pellico C., Nunez Lopez R., Luna Alcala A., Rodrigo Garzon M., Lopez Valdes E., Gomez de la Fuente E., Benito-Leon J., Basalobre Aznar M.D. Clinical manifestations associated with antiphospholipid antibodies. An Med Int 1997; 14: 12: 636-646.
13. Saaden C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998; 91: 3: 220-225.
14. Sherwin A.L., van Gelder N.M. Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. Adv Neurology. New York: Raven Press 1986; 44: 1011-1032.
15. Tanne D., D'Olhaberriague L., Schultz L.R., Salowich-Palm L., Sawaya K.L., Levine S.R. Anticardioli pin antibodies and their associations with cerebrovascular risk factors. Neurology 1999; 22: 52: 7: 1368-1373.